» Articles » PMID: 24653726

Hyaluronan, a Crucial Regulator of Inflammation

Overview
Journal Front Immunol
Date 2014 Mar 22
PMID 24653726
Citations 244
Authors
Affiliations
Soon will be listed here.
Abstract

Hyaluronan (HA), a major component of the extracellular matrix (ECM), plays a key role in regulating inflammation. Inflammation is associated with accumulation and turnover of HA polymers by multiple cell types. Increasingly through the years, HA has become recognized as an active participant in inflammatory, angiogenic, fibrotic, and cancer promoting processes. HA and its binding proteins regulate the expression of inflammatory genes, the recruitment of inflammatory cells, the release of inflammatory cytokines, and can attenuate the course of inflammation, providing protection against tissue damage. A growing body of evidence suggests the cell responses are HA molecular weight dependent. HA fragments generated by multiple mechanisms throughout the course of inflammatory pathologies, elicit cellular responses distinct from intact HA. This review focuses on the role of HA in the promotion and resolution of inflammation.

Citing Articles

Bufadienolide Penetration Through the Skin Membrane and Antiaging Properties of spp. Juices in Dermal Applications.

Hering A, Cal K, Kowalczyk M, Kastsevich A, Ivashchanka Y, Ochocka J Molecules. 2025; 30(4).

PMID: 40005113 PMC: 11858577. DOI: 10.3390/molecules30040802.


Intra-Articular Hyaluronic Acid for Knee Osteoarthritis: A Systematic Umbrella Review.

Glinkowski W, Tomaszewski W J Clin Med. 2025; 14(4).

PMID: 40004802 PMC: 11856182. DOI: 10.3390/jcm14041272.


Hyaluronic Acid is Associated with Severity and Prognosis in Patients with Community-Acquired Pneumonia.

Lin Y, Li Y, Cui X, Zhu N, Li X J Inflamm Res. 2025; 17():11829-11843.

PMID: 39802154 PMC: 11725244. DOI: 10.2147/JIR.S499326.


Targeting hyaluronan synthesis enhances the therapeutic effectiveness of biologics in inflammatory bowel disease.

Xiao P, Chen Z, Cai X, Xia W, Liu X, Song Z JCI Insight. 2025; 10(1.

PMID: 39782690 PMC: 11721290. DOI: 10.1172/jci.insight.180425.


Application of Microsponge Drug Platform to Enhance Methotrexate Administration in Rheumatoid Arthritis Therapy.

Fiaschini N, Hanieh P, Ariaudo D, Cimino R, Abbate C, Romano E Pharmaceutics. 2025; 16(12.

PMID: 39771571 PMC: 11676977. DOI: 10.3390/pharmaceutics16121593.


References
1.
Wisniewski H, Colon E, Liublinska V, Karia R, Stabler T, Attur M . TSG-6 activity as a novel biomarker of progression in knee osteoarthritis. Osteoarthritis Cartilage. 2013; 22(2):235-41. PMC: 3939799. DOI: 10.1016/j.joca.2013.12.004. View

2.
Khaldoyanidi S, Moll J, Karakhanova S, Herrlich P, Ponta H . Hyaluronate-enhanced hematopoiesis: two different receptors trigger the release of interleukin-1beta and interleukin-6 from bone marrow macrophages. Blood. 1999; 94(3):940-9. View

3.
Danilkovitch-Miagkova A, Duh F, Kuzmin I, Angeloni D, Liu S, Miller A . Hyaluronidase 2 negatively regulates RON receptor tyrosine kinase and mediates transformation of epithelial cells by jaagsiekte sheep retrovirus. Proc Natl Acad Sci U S A. 2003; 100(8):4580-5. PMC: 153598. DOI: 10.1073/pnas.0837136100. View

4.
Lesley J, Hascall V, Tammi M, HYMAN R . Hyaluronan binding by cell surface CD44. J Biol Chem. 2000; 275(35):26967-75. DOI: 10.1074/jbc.M002527200. View

5.
Fraser J, Laurent T . Turnover and metabolism of hyaluronan. Ciba Found Symp. 1989; 143:41-53; discussion 53-9, 281-5. View